Ocrelizumab Effects on the Metabolome in MS

NCT03873389 · clinicaltrials.gov ↗

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Ocrelizumab

Sponsor

Johns Hopkins University

Collaborators

[object Object]